The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Alendronate is a drug that is used to treat osteoporosis. The purpose of this study is to
examine whether alendronate in combination with calcium and vitamin D is safe and effective
for treating bone loss in people with HIV.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Alendronate Calcium Calcium Carbonate Calcium, Dietary Ergocalciferols Vitamin D Vitamins